275 related articles for article (PubMed ID: 10323602)
1. JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats.
Ohta T; Furukawa N; Komuro G; Yonemori F; Wakitani K
Br J Pharmacol; 1999 Apr; 126(7):1674-80. PubMed ID: 10323602
[TBL] [Abstract][Full Text] [Related]
2. JTT-608 controls blood glucose by enhancement of glucose-stimulated insulin secretion in normal and diabetes mellitus rats.
Ohta T; Furukawa N; Yonemori F; Wakitani K
Eur J Pharmacol; 1999 Feb; 367(1):91-9. PubMed ID: 10082270
[TBL] [Abstract][Full Text] [Related]
3. Glucose-dependent insulinotropic effects of JTT-608, a novel antidiabetic compound.
Furukawa N; Ohta T; Noguchi T; Yonemori F; Wakitani K
Eur J Pharmacol; 1999 Apr; 371(1):51-8. PubMed ID: 10355594
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic effect of chronic administration of JTT-608, a new hypoglycemic agent, in diabetic Goto-Kakizaki rats.
Ohta T; Miyajima K; Komuro G; Furukawa N; Yonemori F
Eur J Pharmacol; 2003 Aug; 476(1-2):159-66. PubMed ID: 12969761
[TBL] [Abstract][Full Text] [Related]
5. The insulinotropic mechanism of the novel hypoglycaemic agent JTT-608: direct enhancement of Ca(2+) efficacy and increase of Ca(2+) influx by phosphodiesterase inhibition.
Mukai E; Ishida H; Fujimoto S; Kajikawa M; Okamoto Y; Fujita J; Hamamoto Y; Tsuura Y; Yamada Y; Furukawa N; Ohta T; Seino Y
Br J Pharmacol; 2000 Mar; 129(5):901-8. PubMed ID: 10696088
[TBL] [Abstract][Full Text] [Related]
6. 4-(trans-4-Methylcyclohexyl)-4-oxobutyric acid (JTT-608). A new class of antidiabetic agent.
Shinkai H; Ozeki H; Motomura T; Ohta T; Furukawa N; Uchida I
J Med Chem; 1998 Dec; 41(27):5420-8. PubMed ID: 9876112
[TBL] [Abstract][Full Text] [Related]
7.
Zambrana S; Lundqvist LCE; Mamani O; Catrina SB; Gonzales E; Östenson CG
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037028
[No Abstract] [Full Text] [Related]
8. Daily inhibition of postprandial hyperglycaemia with JTT-608, a novel oral antidiabetic agent, ameliorates pancreatic function in neonatally streptozotocin-treated rats.
Ohta T; Sasase T; Miyajima K; Matsui K; Matsushita M; Furukawa N; Yonemori F
Diabetes Obes Metab; 2005 Sep; 7(5):517-24. PubMed ID: 16050944
[TBL] [Abstract][Full Text] [Related]
9. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.
Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T
J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916
[TBL] [Abstract][Full Text] [Related]
10. Effect of high dietary fat on insulin secretion in genetically diabetic Goto-Kakizaki rats.
Shang W; Yasuda K; Takahashi A; Hamasaki A; Takehiro M; Nabe K; Zhou H; Naito R; Fujiwara H; Shimono D; Ueno H; Ikeda H; Toyoda K; Yamada Y; Kurose T
Pancreas; 2002 Nov; 25(4):393-9. PubMed ID: 12409835
[TBL] [Abstract][Full Text] [Related]
11. Both somatostatin and insulin responses to glucose are impaired in the perfused pancreas of the spontaneously noninsulin-dependent diabetic GK (Goto-Kakizaki) rats.
Abdel-Halim SM; Guenifi A; Efendić S; Ostenson CG
Acta Physiol Scand; 1993 Jun; 148(2):219-26. PubMed ID: 8102504
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of protein-tyrosine phosphatases stimulates insulin secretion in pancreatic islets of diabetic Goto-Kakizaki rats.
Chen J; Ostenson CG
Pancreas; 2005 May; 30(4):314-7. PubMed ID: 15841039
[TBL] [Abstract][Full Text] [Related]
13. Possibility of ideal blood glucose control by a new oral hypoglycemic agent, N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166), and its stimulatory effect on insulin secretion in animals.
Sato Y; Nishikawa M; Shinkai H; Sukegawa E
Diabetes Res Clin Pract; 1991 Apr; 12(1):53-9. PubMed ID: 1906797
[TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin-dependent diabetes mellitus.
O'Rourke CM; Davis JA; Saltiel AR; Cornicelli JA
Metabolism; 1997 Feb; 46(2):192-8. PubMed ID: 9030828
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hypoglycemic activity of total lignans from Fructus Arctii in the spontaneously diabetic Goto-Kakizaki rats.
Xu Z; Ju J; Wang K; Gu C; Feng Y
J Ethnopharmacol; 2014; 151(1):548-55. PubMed ID: 24269245
[TBL] [Abstract][Full Text] [Related]
16. An 11-Beta Hydroxysteroid Dehydrogenase Type 1 Inhibitor, JTT-654 Ameliorates Insulin Resistance and Non-obese Type 2 Diabetes.
Heitaku S; Sasase T; Sotani T; Maki M; Katsumi S; Fukuda S; Goto H; Yamamoto H; Nishiu J
Biol Pharm Bull; 2023; 46(7):969-978. PubMed ID: 37394647
[TBL] [Abstract][Full Text] [Related]
17. Effect of gliclazide treatment on insulin secretion and beta-cell mass in non-insulin dependent diabetic Goto-Kakisaki rats.
Dachicourt N; Bailbé D; Gangnerau MN; Serradas P; Ravel D; Portha B
Eur J Pharmacol; 1998 Nov; 361(2-3):243-51. PubMed ID: 9865514
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of hypoglycemic effects of an intestine-specific inhibitor of microsomal triglyceride transfer protein (MTP) in obese rats.
Sakata S; Katsumi S; Mera Y; Kuroki Y; Nashida R; Kakutani M; Ohta T
J Pharmacol Sci; 2015 Jan; 127(1):103-8. PubMed ID: 25704025
[TBL] [Abstract][Full Text] [Related]
19. A new hypoglycemic agent, JTT-608, evokes protein kinase A-mediated Ca(2+) signaling in rat islet beta-cells: strict regulation by glucose, link to insulin release, and cooperation with glucagon-like peptide-1(7-36)amide and pituitary adenylate cyclase-activating polypeptide.
Hashiguchi S; Yada T; Arima T
J Pharmacol Exp Ther; 2001 Jan; 296(1):22-30. PubMed ID: 11123358
[TBL] [Abstract][Full Text] [Related]
20. Amaranthus caudatus Stimulates Insulin Secretion in Goto-Kakizaki Rats, a Model of Diabetes Mellitus Type 2.
Zambrana S; Lundqvist LCE; Veliz V; Catrina SB; Gonzales E; Östenson CG
Nutrients; 2018 Jan; 10(1):. PubMed ID: 29342984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
